Estimates of Mortality Attributable to Influenza and RSV in the United States During 1997-2009 by Influenza Type or Subtype, Age, Cause of Death, and Risk Status
Overview
Authors
Affiliations
Background: Influenza and respiratory syncytial virus (RSV) cause substantial mortality from respiratory and other causes in the USA, especially among people aged 65 and older.
Objectives: We estimated the influenza-attributable mortality and RSV-attributable mortality in the USA, stratified by age and risk status, using outcome definitions with different sensitivity and specificity.
Methods: Influenza- and RSV-associated mortality was assessed from October 1997-March 2009 using multiple linear regression modeling on data obtained from designated government repositories.
Results: The main outcomes and measures included mortality outcome definitions-pneumonia and influenza, respiratory broad, and cardiorespiratory disease. A seasonal average of 10,682 (2287-16,363), 19,100 (4862-29,245), and 28,169 (6797-42,316) deaths was attributed to influenza for pneumonia and influenza, respiratory broad, and cardiorespiratory outcome definitions, respectively. Corresponding values for RSV were 6211 (4584-8169), 11,300 (8546-14,244), and 17,199 (13,384-21,891), respectively. A/H3N2 accounted for seasonal average of 71% influenza-attributable deaths; influenza B accounted for most (51-95%) deaths during four seasons. Approximately 70% influenza-attributable deaths occurred in individuals ≥75 years, with increasing mortality for influenza A/H3N2 and B, but not A/H1N1. In children aged 0-4 years, an average of 97 deaths was attributed to influenza (A/H3N2 = 49, B = 33, A/H1N1 = 15) and 165 to respiratory broad outcome definition (RSV). Influenza-attributable mortality was 2.94-fold higher in high-risk individuals.
Conclusions: Influenza-attributable mortality was highest in older and high-risk individuals and mortality in children was higher than reported in passive Centers for Disease Control and Prevention surveillance. Influenza B-attributable mortality was higher than A in four of 12 seasons. Our estimates represent an updated assessment of influenza-attributable mortality in the USA.
Xu H, Pitzer V, Warren J, Shapiro E, Weinberger D medRxiv. 2025; .
PMID: 39830274 PMC: 11741487. DOI: 10.1101/2025.01.10.24319265.
Miller J, Leedale C, Kang D, Lilue J, Harder O, Niewiesk S J Virol. 2025; 99(2):e0186324.
PMID: 39818970 PMC: 11852932. DOI: 10.1128/jvi.01863-24.
Calabro G, Rizzo C, Domnich A, de Waure C, Rumi F, Bonanni P J Prev Med Hyg. 2024; 65(2 Suppl 1):E1-E159.
PMID: 39554593 PMC: 11567645. DOI: 10.15167/2421-4248/jpmh2024.65.2s1.
Houle S, Luk S Health Sci Rep. 2024; 7(11):e70146.
PMID: 39479285 PMC: 11522622. DOI: 10.1002/hsr2.70146.
Meroc E, Liang C, Iantomasi R, Onwuchekwa C, Innocenti G, dAngela D Infect Dis Ther. 2024; 13(11):2319-2332.
PMID: 39289329 PMC: 11499556. DOI: 10.1007/s40121-024-01041-x.